This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hayes, R J Articles by Cousens, S N Search for Related Content PubMed PubMed Citation Articles by Hayes, R J Articles by Cousens, S N Social Bookmarking                   What's this?

Design and analysis issues in cluster-randomized trials of interventions against infectious diseases

MRC Tropical Epidemiology Group, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK, richard.hayes{at}lshtm.ac.uk

N DE Alexander

MRC Tropical Epidemiology Group, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK

S Bennett

MRC Tropical Epidemiology Group, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK

S N Cousens

MRC Tropical Epidemiology Group, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK

This paper discusses the application of the cluster-randomized trial (CRT) design to evaluate the effectiveness of interventions against infectious diseases. In addition to the usual rationale for this design, there are a number of other advantages that are peculiar to the study of infectious diseases. In particular, CRTs are able to measure the overall effect of an intervention at the population level, capturing both the direct effect of an intervention on an individual's susceptibility to infection, and also the indirect effects due to changes in risks of transmission to other individuals, or to the mass effect or `herd immunity' resulting from intervening in a large proportion of the population.

We briefly review published CRTs of interventions against infectious diseases, most of which have been conducted in the developing countries where such diseases predominate. The focus is on trials in which communities or other large groupings are randomized, and in which impacts on infectious disease incidence or mortality are assessed. We then discuss three issues that are of special relevance to CRTs of infectious diseases. First, issues relating to the definition and size of clusters; secondly, the role of matching or stratification, and the choice of matching factors; and thirdly, the definition of direct and indirect effects of intervention, and methods of assessing these components in a CRT. We conclude by outlining some areas for future research.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Eldridge, D. Ashby, C. Bennett, M. Wakelin, and G. Feder Internal and external validity of cluster randomised trials: systematic review of recent trials BMJ, April 19, 2008; 336(7649): 876 - 880. [Abstract] [Full Text] [PDF]

				D. J. Gray, G. M. Williams, Y. Li, H. Chen, R. S. Li, S. J. Forsyth, A. G. Barnett, J. Guo, Z. Feng, and D. P. McManus A Cluster-Randomized Bovine Intervention Trial against Schistosoma japonicum in the People's Republic of China: Design and Baseline Results Am J Trop Med Hyg, November 1, 2007; 77(5): 866 - 874. [Abstract] [Full Text] [PDF]

				B. Roudsari, R. Fowler, and A. Nathens Intracluster correlation coefficient in multicenter childhood trauma studies Inj. Prev., October 1, 2007; 13(5): 344 - 347. [Abstract] [Full Text] [PDF]

				M. Paul, S. Andreassen, E. Tacconelli, A. D. Nielsen, N. Almanasreh, U. Frank, R. Cauda, L. Leibovici, and on behalf of the TREAT Study Group Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial J. Antimicrob. Chemother., December 1, 2006; 58(6): 1238 - 1245. [Abstract] [Full Text] [PDF]

				M. G Hudgens, P. B Gilbert, and S. G Self Endpoints in vaccine trials Statistical Methods in Medical Research, April 1, 2004; 13(2): 89 - 114. [Abstract] [PDF]

				A. Donner and N. Klar Pitfalls of and Controversies in Cluster Randomization Trials Am J Public Health, March 1, 2004; 94(3): 416 - 422. [Abstract] [Full Text] [PDF]

				D. M. Murray, S. P. Varnell, and J. L. Blitstein Design and Analysis of Group-Randomized Trials: A Review of Recent Methodological Developments Am J Public Health, March 1, 2004; 94(3): 423 - 432. [Abstract] [Full Text] [PDF]

				J. Todd, L. Carpenter, X. Li, J. Nakiyingi, R. Gray, and R. Hayes The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa Int. J. Epidemiol., October 1, 2003; 32(5): 755 - 762. [Abstract] [Full Text] [PDF]

				M. E. Halloran and I. M. Longini Jr. Using Validation Sets for Outcomes and Exposure to Infection in Vaccine Field Studies Am. J. Epidemiol., September 1, 2001; 154(5): 391 - 398. [Abstract] [Full Text] [PDF]

				S. Chinn Statistics for the European Respiratory Journal Eur. Respir. J., August 1, 2001; 18(2): 393 - 401. [Abstract] [Full Text] [PDF]